Nuclear Medicine/Radiopharmaceuticals
Global Nuclear Medicine/Radiopharmaceuticals Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025
Report ID: BMRC 2684 | Number of pages: 198 | Publish Date: Mar 2020 | Category: Lifesciences and HealthcareThe Detailed Market intelligence report on the Global Nuclear Medicine/Radiopharmaceuticals Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Nuclear Medicine/Radiopharmaceuticals Market place for the forecast 2020– 2025.
Scope Of The Report:
Global Nuclear Medicine/Radiopharmaceuticals Market 2020 Industry research report is a proficient and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific). It covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key Vendors operating in this Global market.
Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.
Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Nuclear Medicine/Radiopharmaceuticals Market.
Key Benefits for Nuclear Medicine/Radiopharmaceuticals Market Reports
The analysis provides an exhaustive investigation of the global Nuclear Medicine/Radiopharmaceuticals market together with the future projections to assess the investment feasibility. Furthermore, the report includes both quantitative and qualitative analyses of the Nuclear Medicine/Radiopharmaceuticals market throughout the forecast period. The report also comprehends business opportunities and scope for expansion. Besides this, it provides insights into market threats or barriers and the impact of regulatory framework to give an executive-level blueprint the Nuclear Medicine/Radiopharmaceuticals market. This is done with an aim of helping companies in strategizing their decisions in a better way and finally attains their business goals.
Global market report covers in-depth historical and forecast analysis.
Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
Global market report helps to identify opportunities in market place.
Global market report covers extensive analysis of emerging trends and competitive landscape.
Nuclear Medicine/Radiopharmaceuticals Market Segmentation:
By Type:
- Diagnostic Nuclear Medicine
- Therapeutic Nuclear Medicine
- Brachytherapy Isotopes
By Application:
- Diagnostic Applications
- SPECT Applications
- PET Applications
- Therapeutic Applications
By Procedural Volume Assessment:
- Diagnostic Procedures
- SPECT Procedures
- PET Procedures
- Therapeutic Procedures
- Beta Emitter Procedures
- Alpha Emitter Procedures
- Brachytherapy Procedures
By Region
North America (USA, Canada, Mexico), Europe (UK, France, Germany, Russia, Rest of Europe), Asia-Pacific (China, South Korea, India, Japan, Rest of Asia-Pacific), LAMEA, Latin America, Middle East, Africa
Nuclear Medicine/Radiopharmaceuticals Market Key Players:
- Cardinal Health
- Curium
- GE Healthcare
- Lantheus Medical Imaging, Inc.
- Bayer AG
- Bracco Imaging S.P.A.
- Eczacibasi-Monrol Nuclear Products
- Nordion, Inc. (A Subsidiary of Sterigenics International)
- Advanced Accelerator Applications (AAA) (A Part of Novartis)
- NTP Radioisotopes Soc, LTD.
- Joint Stock Company Isotope (Jsc Isotope)
- Northstar Medical Radioisotopes, LLC
- Eckert & Ziegler
- Jubilant Draximage, Inc. (A Subsidiary of Jubilant Pharma)
- Pharmalogic
- Institute of Isotopes Co., LTD.
- Sinotau Pharmaceuticals Group
- Isotopia Molecular Imaging Limited
- Shine Medical Technologies
- Global Medical Solutions, LTD.
- Right to Win
This comprehensive report will provide:
Enhance your strategic decision making
Assist with your research, presentations and business plans
Show which emerging market opportunities to focus on
Increase your industry knowledge
Keep you up-to-date with crucial market developments
Allow you to develop informed growth strategies
Build your technical insight
Illustrate trends to exploit
Strengthen your analysis of competitors
Provide risk analysis, helping you avoid the pitfalls other companies could make
Ultimately, help you to maximize profitability for your company.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
Which are the driving factors responsible for the growth of market?
Which are the roadblock factors of this market?
What are the new opportunities, by which market will grow in coming years?
What are the trends of this market?
Which are main factors responsible for new product launch?
How big is the global & regional market in terms of revenue, sales and production?
How far will the market grow in forecast period in terms of revenue, sales and production?
Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
Which region has more opportunities?
Table of Content 1. Chapter - Report Methodology 1.1. Research Process 1.2. Primary Research 1.3. Secondary Research 1.4. Market Size Estimates 1.5. Data Triangulation 1.6. Forecast Model 1.7. USP’s of Report 1.8. Report Description 2. Chapter – Global Nuclear Medicine/Radiopharmaceuticals Market Overview: Qualitative Analysis 2.1. Market Introduction 2.2. Executive Summary 2.3. Global Nuclear Medicine/Radiopharmaceuticals Market Classification 2.4. Market Drivers 2.5. Market Restraints 2.6. Market Opportunity 2.7. Nuclear Medicine/Radiopharmaceuticals Market: Trends 2.8. Porter’s Five Forces Analysis 2.8.1. Bargaining Power of Suppliers 2.8.2. Bargaining Power of Consumers 2.8.3. Threat of New Entrants 2.8.4. Threat of Substitute Product and Services 2.8.5. Competitive Rivalry within the Industry 2.9. Market Attractiveness Analysis 2.9.1. Market Attractiveness Analysis by Segmentation 2.9.2. Market Attractiveness Analysis by Region 3. Chapter - Global Nuclear Medicine/Radiopharmaceuticals Market Overview: Quantitative Analysis 3.1. Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025 3.2. Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Market Share (%), 2014- 2025 3.3. Global Nuclear Medicine/Radiopharmaceuticals Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025 3.4. Global Nuclear Medicine/Radiopharmaceuticals Market Sales Market Share (%), 2014- 2025 4. Chapter – Global Nuclear Medicine/Radiopharmaceuticals Market Analysis: Segmentation By Type 5. Chapter – Global Nuclear Medicine/Radiopharmaceuticals Market Analysis: Segmentation By Application 6. Chapter - Global Nuclear Medicine/Radiopharmaceuticals Market Analysis: By Manufacturer 6.1. Global Nuclear Medicine/Radiopharmaceuticals Market Revenue (USD Million), by Manufacturer, 2014 - 2025 6.2. Global Nuclear Medicine/Radiopharmaceuticals Market Share (%), by Manufacturer, 2018 6.3. Global Nuclear Medicine/Radiopharmaceuticals Market Sales (Number of Units), by Manufacturer, 2014 - 2025 6.4. Global Nuclear Medicine/Radiopharmaceuticals Market Share (%), by Manufacturer, 2018 6.5. Global Nuclear Medicine/Radiopharmaceuticals Market Price (USD/Unit), by Manufacturer, 2014 - 2025 6.6. Global Nuclear Medicine/Radiopharmaceuticals Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025 6.7. Merger & Acquisition 6.8. Collaborations and Partnership 6.9. New Product Launch 7. Chapter –Nuclear Medicine/Radiopharmaceuticals Market: Regional Analysis 7.1. North America 7.1.1. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025. 7.1.2. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (USD Million) By Country, 2014 – 2025. 7.1.3. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share (%) By Country, 2014 – 2025. 7.1.4. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.1.5. North America Nuclear Medicine/Radiopharmaceuticals Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.1.6. North America Nuclear Medicine/Radiopharmaceuticals Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025. 7.1.7. North America Nuclear Medicine/Radiopharmaceuticals Market Sales (Number of Units) By Country, 2014 – 2025. 7.1.8. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share (%) By Country, 2014 – 2025. 7.1.9. North America Nuclear Medicine/Radiopharmaceuticals Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.1.10. North America Nuclear Medicine/Radiopharmaceuticals Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025. 7.2. Europe 7.3. Asia Pacific 7.4. Latin America 7.5. Middle East & Africa 8. Chapter - Company Profiles